This study will follow patients after routine surgery of a meniscal allograft transplant.
The BioCleanse meniscus is available to to all orthopedic surgeons for transplantation. The
purpose of this registry is to allow close monitoring of a subgroup of patients receiving
the BioCleanse Meniscus. All patients who have selected a BioCleanse Meniscus for their
Meniscal Allograft transplant will be asked to join the registry. Outcomes will be measured
by subjective subject questionnaires as well as X-rays and MRI.
- All patients, up to 10 who have selected a BioCleanse Meniscus transplant
- Anyone not eligible for a meniscal transplant